ValiRx (LON:VAL) Shares Up 5.6% – What’s Next?
by Danessa Lincoln · The Markets DailyValiRx plc (LON:VAL – Get Free Report)’s share price shot up 5.6% during mid-day trading on Monday . The company traded as high as GBX 0.36 and last traded at GBX 0.36. 13,996,284 shares were traded during mid-day trading, an increase of 95% from the average session volume of 7,178,194 shares. The stock had previously closed at GBX 0.34.
ValiRx Price Performance
The firm has a market capitalization of £2.60 million, a price-to-earnings ratio of -0.38 and a beta of 0.59. The company’s 50 day moving average is GBX 0.37 and its 200 day moving average is GBX 0.52. The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.44.
ValiRx (LON:VAL – Get Free Report) last posted its quarterly earnings data on Monday, September 29th. The company reported GBX (0.22) earnings per share (EPS) for the quarter. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%. On average, equities research analysts anticipate that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
See Also
- Five stocks we like better than ValiRx
- Are Penny Stocks a Good Fit for Your Portfolio?
- Rivian’s Autonomy Bombshell Changes Everything—Even Its Valuation
- How to Plot Fibonacci Price Inflection Levels
- Financial Sector Breaks Out as Capital Rotates and Leadership Shifts
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Super Micro’s Sell-Off Is a Mirage—Here’s Why the Rally May Come Back Fast